CoronavirusCovid-19Health

Pfizer’s At-Home Pill to Treat COVID Could be Available by Year’s End

Pfizer says it could have an at-home oral drug to treat COVID-19 available by the end of the year.

The drug, for which Pfizer began early-stage trials in March, belongs to a class of medicines called protease inhibitors, similar to treatments used for HIV and hepatitis C, CNBC reported.

CEO Albert Bourla said Tuesday on CNBC’s “Squawk Box” that if the clinical trials are successful, the drug could be available nationwide by year’s end, pending approval from the Food and Drug Administration.

Health experts say the drug could be given to newly infected people outside of hospitals early enough to prevent severe illnesses and hospitalizations, CNBC reported.

Meanwhile, Pfizer, which along with German drugmaker BioNTech developed one of a pair of two-dose coronavirus vaccines currently approved by the FDA, is testing its vaccine on children ages 6 months to 11 years old.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker